Second-look surgery is used in restaging patients with ovarian cancer to define sites of recurrence, plan therapy, and perform tumor debulking. We evaluated the role of CT in detecting residual or recurrent tumor in 55 patients in whom 64 abdominopelvic CT scans were obtained. Forty-eight patients underwent a second-look operation, and eight of these patients had an additional third-look operation. CT correctly identified 17 (85%) of 20 cases with residual or recurrent pelvic disease and three (75%) of four cases with bulky abdominal disease. CT failed to detect tumor in any of the five cases with minimal abdominopelvic disease and was able to detect carcinomatosis in only two (8%) of 24 cases. In four cases, CT detected pelvic disease not ...
Abstract Background Ovarian cancer is the second most common gynecologic malignancy. As the primary ...
PURPOSE: To evaluate the accuracy of integrated positron emission tomography (PET) and computed tomo...
The main prognostic factor in ovarian cancer is the stage of disease at diagnosis. The staging syste...
Second-look surgery is used in restaging patients with ovarian cancer to define sites of recurrence,...
Computed tomography (CT scan) was performed on 58 clinically disease-free ovarian cancer patients. T...
Background: Cancer of the ovary is the second commonest gynaecological malignancy after cancer of th...
Background High tumor dissemination (HTD) is a major risk factor for serious morbidity after primary...
This study concerns a selected group of 21 patients with ovarian carcinoma in whom CT, laparotomy, a...
Objectives Computed tomography (CT) is an essential part of preoperative planning prior to cytoreduc...
BACKGROUND: There are no standard approaches for follow up in advanced ovarian cancer (AOC) patien...
Purpose: The usefulness of extensive and repetitive surgery or patients with ovarian cancer still re...
Objective: To compare the diagnostic power of CT scan to a combination of exploratory laparoscopy (E...
PurposeThe purpose of this study was to determine the frequency in which the pelvis component of an ...
Fifty-one patients with a clinically suspected relapse of uterine cancer were evaluated with compute...
PurposeEpithelial ovarian cancer is usually diagnosed in the advanced stages. To choose the best the...
Abstract Background Ovarian cancer is the second most common gynecologic malignancy. As the primary ...
PURPOSE: To evaluate the accuracy of integrated positron emission tomography (PET) and computed tomo...
The main prognostic factor in ovarian cancer is the stage of disease at diagnosis. The staging syste...
Second-look surgery is used in restaging patients with ovarian cancer to define sites of recurrence,...
Computed tomography (CT scan) was performed on 58 clinically disease-free ovarian cancer patients. T...
Background: Cancer of the ovary is the second commonest gynaecological malignancy after cancer of th...
Background High tumor dissemination (HTD) is a major risk factor for serious morbidity after primary...
This study concerns a selected group of 21 patients with ovarian carcinoma in whom CT, laparotomy, a...
Objectives Computed tomography (CT) is an essential part of preoperative planning prior to cytoreduc...
BACKGROUND: There are no standard approaches for follow up in advanced ovarian cancer (AOC) patien...
Purpose: The usefulness of extensive and repetitive surgery or patients with ovarian cancer still re...
Objective: To compare the diagnostic power of CT scan to a combination of exploratory laparoscopy (E...
PurposeThe purpose of this study was to determine the frequency in which the pelvis component of an ...
Fifty-one patients with a clinically suspected relapse of uterine cancer were evaluated with compute...
PurposeEpithelial ovarian cancer is usually diagnosed in the advanced stages. To choose the best the...
Abstract Background Ovarian cancer is the second most common gynecologic malignancy. As the primary ...
PURPOSE: To evaluate the accuracy of integrated positron emission tomography (PET) and computed tomo...
The main prognostic factor in ovarian cancer is the stage of disease at diagnosis. The staging syste...